Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Janus Kinase Inhibitor (Baricitinib) for Aicardi Goutières Syndrome

NCT03921554 is registered in ClinicalTrials.gov with Adeline Vanderver, MD as lead sponsor.

NCT NCT03921554
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03921554 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Janus Kinase Inhibitor (Baricitinib) for Aicardi Goutières Syndrome
Lead sponsor
Adeline Vanderver, MD
Phase
Phase 2
Overall status
Completed
Start date
June 3, 2019
Completion date
March 25, 2024
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aicardi goutieres syndrome